We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

January 5, 2009

Abbott Laboratories et al v. Biovail Laboratories International SRL et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. April 4, 2011

    Abbott, Elan Drop Tricor IP Suits Against Biovail

    Abbott Laboratories and Elan Corp. PLC continued Thursday to wrap up a campaign to block generic versions of the cholesterol drug Tricor, resolving lawsuits against Biovail Corp., which is now owned by Valeant Pharmaceuticals International Inc.


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!